Literature DB >> 17505678

Methylenetetrahydrofolate reductase gene polymorphism and its association with coronary artery disease.

Alexandre Rodrigues Guerzoni1, Erika Cristina Pavarino-Bertelli, Moacir Fernandes de Godoy, Carla Renata Graça, Patrícia Matos Biselli, Dorotéia Rossi Silva Souza, Eny Maria Goloni Bertollo.   

Abstract

CONTEXT AND
OBJECTIVE: Obstructive coronary artery disease (CAD) is characterized by the deposition of atherosclerotic plaque on the coronary artery wall. Its manifestations depend on interactions between environmental and genetic risk factors. The aim of this work was to analyze the frequency of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in patients with CAD and its association with plasma homocysteine levels. Risk factors for CAD were also evaluated. DESIGN AND
SETTING: Retrospective with blind quantitative analysis, at Hospital de Base, Faculdade de Medicina de São José do Rio Preto.
METHODS: One hundred and twenty-seven individuals were studied. All completed a questionnaire to analyze risk factors for CAD. MTHFR polymorphism was investigated by restriction fragment length analysis and correlated with the number of affected arteries and degree of arterial obstruction determined by coronary cineangiography, and with plasma homocysteine levels measured by liquid chromatography/sequential mass spectrometry.
RESULTS: Smoking (p = 0.02) and high-density lipoprotein cholesterol (p = 0.01) were associated with CAD. The C allele was the most prevalent in patients (0.61) and controls (0.66). There was no correlation between MTHFR/C677T polymorphism and plasma homocysteine levels. However, in patients with the TT genotype there was a correlation with the prevalence of coronary obstruction greater than 95% (p = 0.02) and the presence of two affected arteries (p = 0.04).
CONCLUSIONS: The TT genotype is associated with coronary artery obstruction greater than 95% and the presence of two affected arteries. This confirms the relationship between genetic variants in specific patient subgroups and cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17505678     DOI: 10.1590/s1516-31802007000100002

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  8 in total

1.  Mutations in methylenetetrahydrofolate reductase and in cysthationine beta synthase: is there a link to homocysteine levels in peripheral arterial disease?

Authors:  Maria E R C Santos; Francisco das C L E Silva; Karina B Gomes; Ana Paula M Fernandes; Fernanda R Freitas; Mayara C Faria; Ana Paula L Mota; Maria G Carvalho
Journal:  Mol Biol Rep       Date:  2010-11-23       Impact factor: 2.316

2.  Homocysteine and methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in Tunisian patients with severe coronary artery disease.

Authors:  Lakhdar Ghazouani; Nesrine Abboud; Nabil Mtiraoui; Walid Zammiti; Faouzi Addad; Haitham Amin; Wassim Y Almawi; Touhami Mahjoub
Journal:  J Thromb Thrombolysis       Date:  2008-01-19       Impact factor: 2.300

3.  Nutritional status and body composition in patients with peripheral arterial disease: A cross-sectional examination of disease severity and quality of life.

Authors:  Diana P Brostow; Alan T Hirsch; Mark A Pereira; Robin L Bliss; Mindy S Kurzer
Journal:  Ecol Food Nutr       Date:  2015-12-11       Impact factor: 1.692

4.  Genetic polymorphisms involved in folate metabolism and concentrations of methylmalonic acid and folate on plasma homocysteine and risk of coronary artery disease.

Authors:  Patrícia Matos Biselli; Alexandre Rodrigues Guerzoni; Moacir Fernandes de Godoy; Marcos Nogueira Eberlin; Renato Haddad; Valdemir Melechco Carvalho; Hélio Vannucchi; Erika Cristina Pavarino-Bertelli; Eny Maria Goloni-Bertollo
Journal:  J Thromb Thrombolysis       Date:  2009-03-13       Impact factor: 2.300

5.  Interactions between the single nucleotide polymorphisms in the homocysteine pathway (MTHFR 677C>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study.

Authors:  Anke-Hilse Maitland-van der Zee; Amy Lynch; Eric Boerwinkle; Donna K Arnett; Barry R Davis; Catherine Leiendecker-Foster; Charles E Ford; John H Eckfeldt
Journal:  Pharmacogenet Genomics       Date:  2008-08       Impact factor: 2.089

Review 6.  The role of nutrition and body composition in peripheral arterial disease.

Authors:  Diana P Brostow; Alan T Hirsch; Tracie C Collins; Mindy S Kurzer
Journal:  Nat Rev Cardiol       Date:  2012-08-28       Impact factor: 32.419

7.  Vascular endothelial growth factor genetic variability and coronary artery disease in Brazilian population.

Authors:  Patrícia Matos Biselli; Alexandre Rodrigues Guerzoni; Moacir Fernandes de Godoy; Erika Cristina Pavarino-Bertelli; Eny Maria Goloni-Bertollo
Journal:  Heart Vessels       Date:  2008-11-27       Impact factor: 2.037

Review 8.  Recent trends in Brazilian medical research. An overview.

Authors:  Mauricio Rocha-e-Silva
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.